Work

Delay of chemotherapy through use of post-progression erlotinib in patients with EGFR-mutant lung cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7547

Authors: Geoffrey R. Oxnard, Peter Lo, David Michael Jackman, Mohit Butaney, Stephanie Heon, Bruce E Johnson, Lecia V. Sequist, Pasi A. Janne

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2270297461

Cites:

Cited by: 34

Related to: 10